Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Fig. 1

a Relation between hsCRP after 6 weeks treatment with empagliflozin and central pulse pressure after treatment with empagliflozin (r = 0.309, p = 0.018). b Relation between hsCRP after 6 weeks treatment with empagliflozin and reflected wave amplitude after treatment with empagliflozin (r = 0.309, p = 0.020)

Back to article page